carbostyril has been researched along with Liver Failure, Acute in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bjerre, LM; Crispo, JAG; Fortin, Y; Krewski, D; Mattison, D; McNair, D; Momoli, F; Moog, R; Taher, MK | 1 |
| Hirai, S; Hisaka, S; Ichinose, F; Kaneki, M; Shirozu, K; Tanaka, T | 1 |
| Abraham, OC; Balaji, V; George, IA; Kapil, A; Karthik, R; Mitra, S | 1 |
3 other study(ies) available for carbostyril and Liver Failure, Acute
| Article | Year |
|---|---|
Systemic quinolones and risk of acute liver failure III: A nested case-control study using a US electronic health records database.
Topics: Anti-Bacterial Agents; Case-Control Studies; Databases, Factual; Electronic Health Records; Female; Humans; Liver Failure, Acute; Male; Quinolones | 2021 |
Farnesyltransferase inhibitor, tipifarnib, prevents galactosamine/lipopolysaccharide-induced acute liver failure.
Topics: Animals; Caspase 3; Cell Survival; Cytokines; Endotoxemia; Enzyme Inhibitors; Farnesyltranstransferase; Galactosamine; Gene Expression Regulation; Hepatocytes; Inflammation; Interleukin-6; Lipids; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; Quinolones; Sepsis; Tumor Necrosis Factor-alpha | 2014 |
Quinolone-resistant Salmonella enterica Serovar typhi presenting as acute fulminant hepatitis.
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Drug Resistance, Bacterial; Hepatitis A; Humans; Liver Failure, Acute; Male; Microbial Sensitivity Tests; Quinolones; Salmonella typhi; Typhoid Fever | 2009 |